DAPA-HF: Clinical Trial Design Rationale

Published: 11 Oct 2019

  • Views:

    Views Icon 207
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

In this video, Prof Felipe Martinez, Professor of Medicine (Córdoba National University, Córdoba, AR) discusses the design and rationale for DAPA-HF.

Filmed on site at ESC 2019 by Radcliffe Cardiology.

This interview is a component of a wider Radcliffe Education programme entitled,'Current and emerging data on SGLT2 inhibitors in heart failure'. Certified accreditation of the full programme is pending following application to the European Board for Accreditation in Cardiology (EBAC). Once accredited the programme will be available on

Videographer: Tom Green

This video was partially funded by an unrestricted educational grant from AstraZeneca.